IBNCX
Price
$24.91
Change
-$0.01 (-0.04%)
Updated
Sep 5 closing price
Net Assets
2.04B
RLBFX
Price
$38.08
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
257.73B
Interact to see
Advertisement

IBNCX vs RLBFX

Header iconIBNCX vs RLBFX Comparison
Open Charts IBNCX vs RLBFXBanner chart's image
Macquarie Balanced Fund
Price$24.91
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets2.04B
American Funds American Balanced R5
Price$38.08
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets257.73B
IBNCX vs RLBFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IBNCX vs. RLBFX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNCX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 258B vs. IBNCX (2.04B). RLBFX pays higher dividends than IBNCX: RLBFX (2.05) vs IBNCX (0.49). IBNCX was incepted earlier than RLBFX: IBNCX (22 years) vs RLBFX (23 years). IBNCX (1.83) is less costly to investors than RLBFX (0.29). IBNCX is a more actively managed with annual turnover of: 76.00 vs. RLBFX (44.00). RLBFX has a lower initial minimum investment than IBNCX: RLBFX (250) vs IBNCX (1000). IBNCX annual gain was more profitable for investors over the last year : 11.39 vs. RLBFX (10.28). RLBFX return over 5 years is better than : 41.46 vs. IBNCX (2.35).
IBNCXRLBFXIBNCX / RLBFX
Total Expense Ratio1.810.29624%
Annual Report Gross Expense Ratio1.830.29631%
Fund Existence22 years23 years-
Gain YTD8.45211.56273%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.04B258B1%
Annual Yield % from dividends0.492.0524%
Returns for 1 year11.3910.28111%
Returns for 3 years13.0540.9232%
Returns for 5 years2.3541.466%
Returns for 10 years6.9078.409%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGNX9.710.29
+3.08%
REGENXBIO
MANH215.315.45
+2.60%
Manhattan Associates
INCR1.58N/A
+0.27%
Intercure Ltd
DBD59.900.16
+0.27%
Diebold Nixdorf
ADTX0.93N/A
-0.45%
Aditxt Inc